Results 131 to 140 of about 1,942 (152)

Cell-Type Specific Regulation of Cholesterogenesis by CYP46A1 Re-Expression in zQ175 HD Mouse Striatum

open access: yesInternational Journal of Molecular Sciences, 2023
International audienceCholesterol metabolism dysregulation is associated with several neurological disorders. In Huntington’s disease (HD), several enzymes involved in cholesterol metabolism are downregulated, among which the neuronal cholesterol 24 ...
Peter VANHOUTTE   +2 more
exaly   +2 more sources

CYP46A1, the rate-limiting enzyme for cholesterol degradation, is neuroprotective in Huntington's disease. [PDF]

open access: yesBrain, 2016
International audienceHuntington’s disease is an autosomal dominant neurodegenerative disease caused by abnormal polyglutamine expansion in huntingtin (Exp-HTT) leading to degeneration of striatal neurons.
Sandro Alves   +2 more
exaly   +2 more sources

The potential of CYP46A1 as a novel therapeutic target for neurological disorders: An updated review of mechanisms

European Journal of Pharmacology, 2023
Ali Roohbakhsh   +2 more
exaly  

People also looked at

Frontiers in Aging Neuroscience, 2020
Hua-Dong Zhou, Yan-Jiang Wang, Fan Zeng
exaly  

Cholesterol 24-Hydroxylation by CYP46A1: Benefits of Modulation for Brain Diseases

Neurotherapeutics, 2019
Irina Pikuleva, Alexey M. Petrov
exaly  

Neuronal differentiation alters the ratio of Sp transcription factors recruited to the CYP46A1 promoter.

Journal of Neurochemistry, 2012
Maria João Nunes   +2 more
exaly  

Home - About - Disclaimer - Privacy